Diabetes regulates fructose absorption through thioredoxin-interacting protein

eLife

Volumn 5, Issue OCTOBER2016, 2016, Pages

  Dotimas, James R ^a,b   Lee, Austin W ^a,b   Schmider, Angela B ^c   Carroll, Shannon H ^a,b   Shah, Anu ^a,b   Bilen, Julide ^a,b   Elliott, Kayla R ^a,b   Myers, Ronald B ^a,b   Soberman, Roy J ^c   Yoshioka, Jun ^a,b   Lee, Richard T ^a,b  

^a HARVARD UNIVERSITY   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FRUCTOSE; GLUCOSE; GLUCOSE TRANSPORTER 1; GLUCOSE TRANSPORTER 2; GLUCOSE TRANSPORTER 5; INSULIN; STREPTOZOCIN; THIOREDOXIN INTERACTING PROTEIN; CARRIER PROTEIN; THIOREDOXIN; TXNIP PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARBOHYDRATE ABSORPTION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DIABETES MELLITUS; FLUORESCENCE MICROSCOPY; FRUCTOSE ABSORPTION; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE TOLERANCE TEST; HYPERGLYCEMIA; IMMUNOBLOTTING; LIVER HISTOLOGY; MOLECULAR INTERACTION; MOUSE; NONHUMAN; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ADSORPTION; ANIMAL; C57BL MOUSE; DISEASE MODEL; KNOCKOUT MOUSE; METABOLISM; PATHOPHYSIOLOGY;

ADSORPTION; ANIMALS; CARRIER PROTEINS; DIABETES MELLITUS; DISEASE MODELS, ANIMAL; FRUCTOSE; MICE, INBRED C57BL; MICE, KNOCKOUT; THIOREDOXINS;

EID: 84991302315     PISSN: None     EISSN: 2050084X     Source Type: Journal    
DOI: 10.7554/eLife.18313.001     Document Type: Article

References (43)

1. Abdelmalek MF, Suzuki A, Guy C, Unalp-Arida A, Colvin R, Johnson RJ, Diehl AM, Nonalcoholic Steatohepatitis Clinical Research Network. 2010. Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease. Hepatology 51:1961-1971. doi: 10.1002/hep.23535
2. Asano T, Katagiri H, Tsukuda K, Lin JL, Ishihara H, Yazaki Y, Oka Y. 1992. Upregulation of GLUT2 mRNA by glucose, mannose, and fructose in isolated rat hepatocytes. Diabetes 41:22-25. doi: 10.2337/diab.41.1.22
3. Burant CF, Takeda J, Brot-Laroche E, Bell GI, Davidson NO. 1992. Fructose transporter in human spermatozoa and small intestine is GLUT5. Journal of Biological Chemistry 267:14523-14526.
4. Burgess K, Xu T, Brown R, Han B, Welle S. 2011. Effect of myostatin depletion on weight gain, hyperglycemia, and hepatic steatosis during five months of high-fat feeding in mice. PLoS One 6:e17090. doi: 10.1371/journal.pone.0017090
5. Cha-Molstad H, Saxena G, Chen J, Shalev A. 2009. Glucose-stimulated expression of Txnip is mediated by carbohydrate response element-binding protein, p300, and histone H4 acetylation in pancreatic beta cells. Journal of Biological Chemistry 284:16898-16905. doi: 10.1074/jbc.M109.010504
6. Chutkow WA, Patwari P, Yoshioka J, Lee RT. 2008. Thioredoxin-interacting protein (Txnip) is a critical regulator of hepatic glucose production. Journal of Biological Chemistry 283:2397-2406. doi: 10.1074/jbc.M708169200
7. Cox TM. 2002. The genetic consequences of our sweet tooth. Nature Reviews Genetics 3:481-487. doi: 10.1038/nrg815
8. Douard V, Ferraris RP. 2008. Regulation of the fructose transporter GLUT5 in health and disease. AJP: Endocrinology and Metabolism 295:E227-E237. doi: 10.1152/ajpendo.90245.2008
9. Engle MJ, Goetz GS, Alpers DH. 1998. Caco-2 cells express a combination of colonocyte and enterocyte phenotypes. Journal of Cellular Physiology 174:362-369. doi: 10.1002/(SICI)1097-4652(199803)174:3<362::AID-JCP10>3.0.CO;2-B
10. Gould GW, Thomas HM, Jess TJ, Bell GI. 1991. Expression of human glucose transporters in Xenopus oocytes: kinetic characterization and substrate specificities of the erythrocyte, liver, and brain isoforms. Biochemistry 30: 5139-5145. doi: 10.1021/bi00235a004
11. Gouyon F, Caillaud L, Carriere V, Klein C, Dalet V, Citadelle D, Kellett GL, Thorens B, Leturque A, Brot-Laroche E. 2003. Simple-sugar meals target GLUT2 at enterocyte apical membranes to improve sugar absorption: a study in GLUT2-null mice. The Journal of Physiology 552:823-832. doi: 10.1113/jphysiol.2003.049247
12. Helliwell PA, Richardson M, Affleck J, Kellett GL. 2000. Stimulation of fructose transport across the intestinal brush-border membrane by PMA is mediated by GLUT2 and dynamically regulated by protein kinase C. Biochemical Journal 350 (Pt 1):149-154. doi: 10.1042/bj3500149
13. Hidalgo IJ, Raub TJ, Borchardt RT. 1989. Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability. Gastroenterology 96:736-749. doi: 10.1016/S0016-5085(89)80072-1
14. Holloway PA, Parsons DS. 1984. Absorption and metabolism of fructose by rat jejunum. Biochemical Journal 222:57-64. doi: 10.1042/bj2220057
15. Hwang LL, Wang CH, Li TL, Chang SD, Lin LC, Chen CP, Chen CT, Liang KC, Ho IK, Yang WS, Chiou LC. 2010. Sex differences in high-fat diet-induced obesity, metabolic alterations and learning, and synaptic plasticity deficits in mice. Obesity 18:463-469. doi: 10.1038/oby.2009.273
16. Johnson RJ, Segal MS, Sautin Y, Nakagawa T, Feig DI, Kang DH, Gersch MS, Benner S, Sá nchez-Lozada LG. 2007. Potential role of sugar (fructose) in the epidemic of hypertension, obesity and the metabolic syndrome, diabetes, kidney disease, and cardiovascular disease. The American Journal of Clinical Nutrition 86:899-906.
17. Kawasaki T, Akanuma H, Yamanouchi T. 2002. Increased fructose concentrations in blood and urine in patients with diabetes. Diabetes Care 25:353-357. doi: 10.2337/diacare.25.2.353
18. Kellett GL, Brot-Laroche E. 2005. Apical GLUT2: a major pathway of intestinal sugar absorption. Diabetes 54: 3056-3062. doi: 10.2337/diabetes.54.10.3056
19. Kellett GL, Helliwell PA. 2000. The diffusive component of intestinal glucose absorption is mediated by the glucose-induced recruitment of GLUT2 to the brush-border membrane. Biochemical Journal 350:155-162. doi: 10.1042/bj3500155
20. Kellett GL. 2001. The facilitated component of intestinal glucose absorption. Journal of Physiology 531:585-595. doi: 10.1111/j.1469-7793.2001.0585h.x
21. Li W, Wu Z, Ma Q, Liu J, Xu Q, Han L, Duan W, Lv Y, Wang F, Reindl KM, Wu E. 2014. Hyperglycemia regulates TXNIP/TRX/ROS axis via p38 MAPK and ERK pathways in pancreatic cancer. Current Cancer Drug Targets 14: 348-356. doi: 10.2174/1568009614666140331231658
22. Li X, Rong Y, Zhang M, Wang XL, LeMaire SA, Coselli JS, Zhang Y, Shen YH. 2009. Up-regulation of thioredoxin interacting protein (Txnip) by p38 MAPK and FOXO1 contributes to the impaired thioredoxin activity and increased ROS in glucose-treated endothelial cells. Biochemical and Biophysical Research Communications 381:660-665. doi: 10.1016/j.bbrc.2009.02.132
23. Mayes PA. 1993. Intermediary metabolism of fructose. The American Journal of Clinical Nutrition 58:754S-765S.
24. Morgan EL, Mace OJ, Affleck J, Kellett GL. 2007. Apical GLUT2 and Cav1.3: regulation of rat intestinal glucose and calcium absorption. Journal of Physiology 580:593-604. doi: 10.1113/jphysiol.2006.124768
25. Morselli E, Criollo A, Rodriguez-Navas C, Clegg DJ. 2014. Chronic high fat diet consumption impairs metabolic health of male mice. Inflammation and Cell Signaling 1:e561. doi: 10.14800/ics.561
26. Muoio DM. 2007. TXNIP links redox circuitry to glucose control. Cell Metabolism 5:412-414. doi: 10.1016/j.cmet.2007.05.011
27. Ouyang X, Cirillo P, Sautin Y, McCall S, Bruchette JL, Diehl AM, Johnson RJ, Abdelmalek MF. 2008. Fructose consumption as a risk factor for non-alcoholic fatty liver disease. Journal of Hepatology 48:993-999. doi: 10.1016/j.jhep.2008.02.011
28. Parikh H, Carlsson E, Chutkow WA, Johansson LE, Storgaard H, Poulsen P, Saxena R, Ladd C, Schulze PC, Mazzini MJ, Jensen CB, Krook A, Björnholm M, Tornqvist H, Zierath JR, Ridderstrå le M, Altshuler D, Lee RT, Vaag A, Groop LC, et al. 2007. TXNIP regulates peripheral glucose metabolism in humans. PLoS Medicine 4: e158. doi: 10.1371/journal.pmed.0040158
29. Patwari P, Chutkow WA, Cummings K, Verstraeten VL, Lammerding J, Schreiter ER, Lee RT. 2009. Thioredoxin-independent regulation of metabolism by the alpha-arrestin proteins. Journal of Biological Chemistry 284: 24996-25003. doi: 10.1074/jbc.M109.018093
30. Patwari P, Higgins LJ, Chutkow WA, Yoshioka J, Lee RT. 2006. The interaction of thioredoxin with Txnip. Evidence for formation of a mixed disulfide by disulfide exchange. Journal of Biological Chemistry 281:21884-21891. doi: 10.1074/jbc.M600427200
31. Patwari P, Lee RT. 2012. An expanded family of arrestins regulate metabolism. Trends in Endocrinology & Metabolism 23:216-222. doi: 10.1016/j.tem.2012.03.003
32. Pitkänen E. 1996. Mannose, mannitol, fructose and 1,5-anhydroglucitol concentrations measured by gas chromatography/mass spectrometry in blood plasma of diabetic patients. Clinica Chimica Acta 251:91-103. doi: 10.1016/0009-8981(96)06284-5
33. Riby JE, Fujisawa T, Kretchmer N. 1993. Fructose absorption. The American Journal of Clinical Nutrition 58: 748S-753.
34. Shalev A, Pise-Masison CA, Radonovich M, Hoffmann SC, Hirshberg B, Brady JN, Harlan DM. 2002. Oligonucleotide microarray analysis of intact human pancreatic islets: identification of glucose-responsive genes and a highly regulated TGFbeta signaling pathway. Endocrinology 143:3695-3698. doi: 10.1210/en.2002-220564
35. Shalev A. 2014. Minireview: Thioredoxin-interacting protein: regulation and function in the pancreatic b-cell. Molecular Endocrinology 28:1211-1220. doi: 10.1210/me.2014-1095
36. Stanhope KL. 2016. Sugar consumption, metabolic disease and obesity: The state of the controversy. Critical Reviews in Clinical Laboratory Sciences 53:52-67. doi: 10.3109/10408363.2015.1084990
37. Stevenson RJ, Boakes RA, Oaten MJ, Yeomans MR, Mahmut M, Francis HM. 2016. Chemosensory abilities in consumers of a western-style diet. Chemical Senses 41:505-513. doi: 10.1093/chemse/bjw053
38. Stoltzman CA, Peterson CW, Breen KT, Muoio DM, Billin AN, Ayer DE. 2008. Glucose sensing by MondoA:Mlx complexes: a role for hexokinases and direct regulation of thioredoxin-interacting protein expression. PNAS 105:6912-6917. doi: 10.1073/pnas.0712199105
39. Sugawara-Yokoo M, Suzuki T, Matsuzaki T, Naruse T, Takata K. 1999. Presence of fructose transporter GLUT5 in the S3 proximal tubules in the rat kidney. Kidney International 56:1022-1028. doi: 10.1046/j.1523-1755.1999.00635.x
40. Wei Y, Pagliassotti MJ. 2004. Hepatospecific effects of fructose on c-jun NH2-terminal kinase: implications for hepatic insulin resistance. AJP: Endocrinology and Metabolism 287:E926-E933. doi: 10.1152/ajpendo.00185.2004
41. Wu N, Zheng B, Shaywitz A, Dagon Y, Tower C, Bellinger G, Shen CH, Wen J, Asara J, McGraw TE, Kahn BB, Cantley LC. 2013. AMPK-dependent degradation of TXNIP upon energy stress leads to enhanced glucose uptake via GLUT1. Molecular Cell 49:1167-1175. doi: 10.1016/j.molcel.2013.01.035
42. Xu G, Chen J, Jing G, Shalev A. 2012. Preventing b-cell loss and diabetes with calcium channel blockers. Diabetes 61:848-856. doi: 10.2337/db11-0955
43. Zierath JR, Nolte LA, Wahlström E, Galuska D, Shepherd PR, Kahn BB, Wallberg-Henriksson H. 1995. Carrier-mediated fructose uptake significantly contributes to carbohydrate metabolism in human skeletal muscle. Biochemical Journal 311 (Pt 2):517-521. doi: 10.1042/bj3110517